Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2025-12-24 @ 9:07 PM
NCT ID: NCT00854204
Eligibility Criteria: Inclusion Criteria: * Non-smoking for at least 3 months prior to selection * Normal weight as defined by a Body Mass Index (BMI, weight in kg divided by the square of height in meters) of 18.0 to 30.0 kg/m2, extremes included * Informed Consent Form (ICF) signed voluntarily before the first trial-related activity * Able to comply with protocol requirements * Healthy on the basis of a medical evaluation that confirms the absence of any clinically relevant abnormality and includes a physical examination, medical history, the results of blood biochemistry, coagulation, and hematology tests, a urinalysis, vital signs, and a 12-lead electrocardiogram (ECG) (in triplicate) with the following parameters carried out at screening: a. heart rate (HR) between 40 and 100 bpm * b. QTc interval = 450 ms * c. QRS interval lower than 120 ms * d. PR interval = 220 ms. Exclusion Criteria: * Past history of heart arrhythmias * History or evidence of current use of alcohol, barbiturate, amphetamine, recreational or narcotic drug use, which in the investigator's opinion would compromise subject's safety and/or compliance with the trial procedures * Hepatitis A, B, or C infection or HIV-1 or HIV-2 infection at screening * Currently active or underlying gastrointestinal, cardiovascular, neurologic, psychiatric, metabolic, endocrinologic, genitourinary, renal, hepatic, respiratory, inflammatory, or infectious disease * Any history of significant skin disease and allergy to drugs
Healthy Volunteers: True
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT00854204
Study Brief:
Protocol Section: NCT00854204